Senator’s bipartisan legislation designates July 20, 2022 as National Glioblastoma Awareness Day
WASHINGTON – The U.S. Senate passed Arizona senior Senator Kyrsten Sinema’s bipartisan legislation designating July 20, 2022 as National Glioblastoma Awareness Day. Sinema’s bipartisan resolution calls for greater efforts to help advance treatment, caregiving, and general care options for brain cancers – honoring the legacy of the late Arizona senior Senator John McCain.
“Our bipartisan resolution honoring John McCain and other Americans who have battled glioblastoma will strengthen efforts towards finding new treatments for this disease and other brain cancers,” said Sinema.
Sinema’s bipartisan legislation calls for treatments of glioblastoma and related brain cancers to slow its progression, improve quality of life, and recognize the importance of molecular biomarker testing to improve diagnosis and treatment.
In January, Sinema led the entire bipartisan Arizona congressional delegation supporting University of Arizona’s Cancer Center application renewal of its National Cancer Institute Cancer Center Support Grant. Researchers at the University have led groundbreaking research in searching for genetic differences between glioblastoma cells from long- and short-term survivors.
In 2020, the National Cancer Institute established the Glioblastoma Therapeutics Network to enhance and support the discovery and development of glioblastoma therapies. Sinema’s resolution calls for continued federal investments into the Glioblastoma Therapeutics Network.